Landscapes / Companies
Celldex Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 7 in all
Trials
7 active
19 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Phase 3 | Jun 2028Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Jun 2028 · Phase 3 trial completes | ||||
| Also tested for | Chronic Spontaneous Urticaria, Prurigo Nodularis and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2027Phase 1 trial completes | |||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Mild to Moderate Asthma | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021